1: Gao XY, Liu Y, Miao LL, Li EW, Hou TT, Liu ZP. Mechanism of anti-Vibrio activity of marine probiotic strain Bacillus pumilus H2, and characterization of the active substance. AMB Express. 2017 Dec;7(1):23. doi: 10.1186/s13568-017-0323-3. Epub 2017 Jan 17. PubMed PMID: 28097594; PubMed Central PMCID: PMC5241254.
2: Prokhorova IV, Akulich KA, Makeeva DS, Osterman IA, Skvortsov DA, Sergiev PV, Dontsova OA, Yusupova G, Yusupov MM, Dmitriev SE. Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome. Sci Rep. 2016 Jun 14;6:27720. doi: 10.1038/srep27720. PubMed PMID: 27296282; PubMed Central PMCID: PMC4906347.
3: Melnikov SV, Söll D, Steitz TA, Polikanov YS. Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome. Nucleic Acids Res. 2016 Jun 2;44(10):4978-87. doi: 10.1093/nar/gkw246. Epub 2016 Apr 13. PubMed PMID: 27079977; PubMed Central PMCID: PMC4889946.
4: Jiang J, Seo H, Chow CS. Post-transcriptional Modifications Modulate rRNA Structure and Ligand Interactions. Acc Chem Res. 2016 May 17;49(5):893-901. doi: 10.1021/acs.accounts.6b00014. Epub 2016 Apr 11. PubMed PMID: 27064497.
5: Li Y, Li Z, Yamanaka K, Xu Y, Zhang W, Vlamakis H, Kolter R, Moore BS, Qian PY. Directed natural product biosynthesis gene cluster capture and expression in the model bacterium Bacillus subtilis. Sci Rep. 2015 Mar 24;5:9383. doi: 10.1038/srep09383. PubMed PMID: 25807046; PubMed Central PMCID: PMC4894447.
6: Polikanov YS, Osterman IA, Szal T, Tashlitsky VN, Serebryakova MV, Kusochek P, Bulkley D, Malanicheva IA, Efimenko TA, Efremenkova OV, Konevega AL, Shaw KJ, Bogdanov AA, Rodnina MV, Dontsova OA, Mankin AS, Steitz TA, Sergiev PV. Amicoumacin a inhibits translation by stabilizing mRNA interaction with the ribosome. Mol Cell. 2014 Nov 20;56(4):531-40. doi: 10.1016/j.molcel.2014.09.020. Epub 2014 Oct 9. PubMed PMID: 25306919; PubMed Central PMCID: PMC4253140.
7: Lama A, Pané-Farré J, Chon T, Wiersma AM, Sit CS, Vederas JC, Hecker M, Nakano MM. Response of methicillin-resistant Staphylococcus aureus to amicoumacin A. PLoS One. 2012;7(3):e34037. doi: 10.1371/journal.pone.0034037. Epub 2012 Mar 30. PubMed PMID: 22479511; PubMed Central PMCID: PMC3316591.
8: Li Y, Xu Y, Liu L, Han Z, Lai PY, Guo X, Zhang X, Lin W, Qian PY. Five new amicoumacins isolated from a marine-derived bacterium Bacillus subtilis. Mar Drugs. 2012 Feb;10(2):319-28. doi: 10.3390/md10020319. Epub 2012 Feb 3. PubMed PMID: 22412803; PubMed Central PMCID: PMC3296999.
9: Hashimoto M, Taguchi T, Nishida S, Ueno K, Koizumi K, Aburada M, Ichinose K. Isolation of 8'-phosphate ester derivatives of amicoumacins: structure-activity relationship of hydroxy amino acid moiety. J Antibiot (Tokyo). 2007 Dec;60(12):752-6. doi: 10.1038/ja.2007.99. Erratum in: J Antibiot (Tokyo). 2008 Jan;61(1):C-1. PubMed PMID: 18277000.
10: Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Mégraud F, Urdaci MC. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother. 2001 Nov;45(11):3156-61. PubMed PMID: 11600371; PubMed Central PMCID: PMC90797.
11: Itoh J, Omoto S, Shomura T, Nishizawa N, Miyado S, Yuda Y, Shibata U, Inouye S. Amicoumacin-A, a new antibiotic with strong antiinflammatory and antiulcer activity. J Antibiot (Tokyo). 1981 May;34(5):611-3. PubMed PMID: 7275843.